Results of selective neck dissection in management of the node-positive neck

Peter Andersen, Frank Warren, Jeffrey Spiro, Alan Burningham, Richard Wong, Mark Wax, Jatin P. Shah, James Cohen

Research output: Contribution to journalArticle

92 Citations (Scopus)

Abstract

Background: Although increasingly accepted in treatment of the NO neck, use of selective neck dissection in patients with node-positive squamous cell carcinoma of the head and neck remains controversial. Objective: To determine the oncologic efficacy of selective node dissection in patients with node-positive squamous carcinoma of the head and neck. Setting: Three tertiary care academic/Veterans Affairs medical centers. Methods: Ten-year retrospective medical chart review of 106 previously untreated clinically and pathologically node-positive patients undergoing 129 selective neck dissections and followed for a minimum of 2 years or until patient death. Results: Regional metastasis was clinically staged as N1 in 58 patients (54.7%), N2a in 5 (4.7%), N2b in 28 (26.4%), N2c in 14 (13.2%), and N3 in 1 (0.9%). Extracapsular extension of tumor was present in 36 patients (34.0%), and postoperative radiation therapy was administered to 76 patients (71.7%). Overall, 9 patients experienced disease recurrence in the neck. Six of these recurrences were in the side of the neck that had undergone selective neck dissection, for a regional control rate of 94.3%. Conclusions: These results support the use of selective neck dissection in carefully selected patients with clinically node-positive squamous cell carcinoma of the head and neck region. Regional control rates comparable to those achieved with comprehensive operations can be achieved in appropriately selected patients.

Original languageEnglish (US)
Pages (from-to)1180-1184
Number of pages5
JournalArchives of Otolaryngology - Head and Neck Surgery
Volume128
Issue number10
StatePublished - Oct 1 2002

Fingerprint

Neck Dissection
Neck
Recurrence
Veterans
Tertiary Healthcare
Dissection
Squamous Cell Carcinoma
Radiotherapy
Head
Neoplasm Metastasis

ASJC Scopus subject areas

  • Otorhinolaryngology

Cite this

Results of selective neck dissection in management of the node-positive neck. / Andersen, Peter; Warren, Frank; Spiro, Jeffrey; Burningham, Alan; Wong, Richard; Wax, Mark; Shah, Jatin P.; Cohen, James.

In: Archives of Otolaryngology - Head and Neck Surgery, Vol. 128, No. 10, 01.10.2002, p. 1180-1184.

Research output: Contribution to journalArticle

Andersen, Peter ; Warren, Frank ; Spiro, Jeffrey ; Burningham, Alan ; Wong, Richard ; Wax, Mark ; Shah, Jatin P. ; Cohen, James. / Results of selective neck dissection in management of the node-positive neck. In: Archives of Otolaryngology - Head and Neck Surgery. 2002 ; Vol. 128, No. 10. pp. 1180-1184.
@article{81058dec699543c5af17ba39bee7e9df,
title = "Results of selective neck dissection in management of the node-positive neck",
abstract = "Background: Although increasingly accepted in treatment of the NO neck, use of selective neck dissection in patients with node-positive squamous cell carcinoma of the head and neck remains controversial. Objective: To determine the oncologic efficacy of selective node dissection in patients with node-positive squamous carcinoma of the head and neck. Setting: Three tertiary care academic/Veterans Affairs medical centers. Methods: Ten-year retrospective medical chart review of 106 previously untreated clinically and pathologically node-positive patients undergoing 129 selective neck dissections and followed for a minimum of 2 years or until patient death. Results: Regional metastasis was clinically staged as N1 in 58 patients (54.7{\%}), N2a in 5 (4.7{\%}), N2b in 28 (26.4{\%}), N2c in 14 (13.2{\%}), and N3 in 1 (0.9{\%}). Extracapsular extension of tumor was present in 36 patients (34.0{\%}), and postoperative radiation therapy was administered to 76 patients (71.7{\%}). Overall, 9 patients experienced disease recurrence in the neck. Six of these recurrences were in the side of the neck that had undergone selective neck dissection, for a regional control rate of 94.3{\%}. Conclusions: These results support the use of selective neck dissection in carefully selected patients with clinically node-positive squamous cell carcinoma of the head and neck region. Regional control rates comparable to those achieved with comprehensive operations can be achieved in appropriately selected patients.",
author = "Peter Andersen and Frank Warren and Jeffrey Spiro and Alan Burningham and Richard Wong and Mark Wax and Shah, {Jatin P.} and James Cohen",
year = "2002",
month = "10",
day = "1",
language = "English (US)",
volume = "128",
pages = "1180--1184",
journal = "JAMA Otolaryngology - Head and Neck Surgery",
issn = "2168-6181",
publisher = "American Medical Association",
number = "10",

}

TY - JOUR

T1 - Results of selective neck dissection in management of the node-positive neck

AU - Andersen, Peter

AU - Warren, Frank

AU - Spiro, Jeffrey

AU - Burningham, Alan

AU - Wong, Richard

AU - Wax, Mark

AU - Shah, Jatin P.

AU - Cohen, James

PY - 2002/10/1

Y1 - 2002/10/1

N2 - Background: Although increasingly accepted in treatment of the NO neck, use of selective neck dissection in patients with node-positive squamous cell carcinoma of the head and neck remains controversial. Objective: To determine the oncologic efficacy of selective node dissection in patients with node-positive squamous carcinoma of the head and neck. Setting: Three tertiary care academic/Veterans Affairs medical centers. Methods: Ten-year retrospective medical chart review of 106 previously untreated clinically and pathologically node-positive patients undergoing 129 selective neck dissections and followed for a minimum of 2 years or until patient death. Results: Regional metastasis was clinically staged as N1 in 58 patients (54.7%), N2a in 5 (4.7%), N2b in 28 (26.4%), N2c in 14 (13.2%), and N3 in 1 (0.9%). Extracapsular extension of tumor was present in 36 patients (34.0%), and postoperative radiation therapy was administered to 76 patients (71.7%). Overall, 9 patients experienced disease recurrence in the neck. Six of these recurrences were in the side of the neck that had undergone selective neck dissection, for a regional control rate of 94.3%. Conclusions: These results support the use of selective neck dissection in carefully selected patients with clinically node-positive squamous cell carcinoma of the head and neck region. Regional control rates comparable to those achieved with comprehensive operations can be achieved in appropriately selected patients.

AB - Background: Although increasingly accepted in treatment of the NO neck, use of selective neck dissection in patients with node-positive squamous cell carcinoma of the head and neck remains controversial. Objective: To determine the oncologic efficacy of selective node dissection in patients with node-positive squamous carcinoma of the head and neck. Setting: Three tertiary care academic/Veterans Affairs medical centers. Methods: Ten-year retrospective medical chart review of 106 previously untreated clinically and pathologically node-positive patients undergoing 129 selective neck dissections and followed for a minimum of 2 years or until patient death. Results: Regional metastasis was clinically staged as N1 in 58 patients (54.7%), N2a in 5 (4.7%), N2b in 28 (26.4%), N2c in 14 (13.2%), and N3 in 1 (0.9%). Extracapsular extension of tumor was present in 36 patients (34.0%), and postoperative radiation therapy was administered to 76 patients (71.7%). Overall, 9 patients experienced disease recurrence in the neck. Six of these recurrences were in the side of the neck that had undergone selective neck dissection, for a regional control rate of 94.3%. Conclusions: These results support the use of selective neck dissection in carefully selected patients with clinically node-positive squamous cell carcinoma of the head and neck region. Regional control rates comparable to those achieved with comprehensive operations can be achieved in appropriately selected patients.

UR - http://www.scopus.com/inward/record.url?scp=0036793275&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0036793275&partnerID=8YFLogxK

M3 - Article

C2 - 12365890

AN - SCOPUS:0036793275

VL - 128

SP - 1180

EP - 1184

JO - JAMA Otolaryngology - Head and Neck Surgery

JF - JAMA Otolaryngology - Head and Neck Surgery

SN - 2168-6181

IS - 10

ER -